Dermaliq Therapeutics, Inc.
PrivateLast Round
Strategic
May 28, 2025
Total Funding Raised
$15M
Company Overview
Dermaliq Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Wilmington, Delaware. Its latest recorded funding round was a Strategic round in May 2025.
Dermaliq Therapeutics, Inc. is a clinical-stage dermatology company developing topical therapies for follicular diseases and conditions using its proprietary hyliQ® technology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dermaliq Therapeutics, Inc. Comparables
Compare Dermaliq Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alys Pharmaceuticals | 79% | |
| Atticus Pharma | 79% | |
| Follicle Pharma | 77% |
For institutional investors. Book with your work email.
Dermaliq Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 28, 2025 | ||||
| Series B | Feb 5, 2025 | ||||
| Series A | Jan 18, 2022 |
For institutional investors. Book with your work email.
Dermaliq Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DEBRA Research gGmbH | Strategic |
Dermaliq Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dermaliq Therapeutics, Inc.'s valuation, stock price, and market status.
Is Dermaliq Therapeutics, Inc. a public or private company?
Dermaliq Therapeutics, Inc. is a private company.
What is the current stock price of Dermaliq Therapeutics, Inc.?
Dermaliq Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Dermaliq Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dermaliq Therapeutics, Inc. worth (valuation)?
Valuation information for Dermaliq Therapeutics, Inc. is not publicly available.
Can I buy Dermaliq Therapeutics, Inc. stock?
Dermaliq Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dermaliq Therapeutics, Inc.'s last funding round?
Dermaliq Therapeutics, Inc.'s most recent funding round was Strategic on May 28, 2025.
Who are the main investors in Dermaliq Therapeutics, Inc.?
Key investors in Dermaliq Therapeutics, Inc. include DEBRA Research gGmbH.
Will Dermaliq Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Dermaliq Therapeutics, Inc..
How can I track Dermaliq Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Dermaliq Therapeutics, Inc.'s shares on secondary markets.